Theodore R. Breitman

Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing agents.

Inge Olsson, Theodore R. Breitman · PubMed · 1982 · 214 citations

Life Sciences, Cell Biology, Pharmacology +9

Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor.

Inge Olsson, Theodore R. Breitman, Robert C. Gallo · PubMed · 1982 · 179 citations

Life Sciences, Cell Biology, Oncology +13

Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells.

Sidney Strickland, Theodore R. Breitman, Fritz Frickel et al. · PubMed · 1983 · 105 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Conformationally Defined Retinoic Acid Analogues. 4. Potential New Agents for Acute Promyelocytic and Juvenile Myelomonocytic Leukemias

Donald D. Muccio, Wayne J. Brouillette, Theodore R. Breitman et al. · Journal of Medicinal Chemistry · 1998 · 55 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.

Dario Ferrero, Corrado Tarella, Eugenio Gallo et al. · PubMed · 1982 · 55 citations

Medicine, Cell Biology, Oncology +17